(dp0
S'ovarian cancer'
p1
(dp2
S'number positive'
p3
I1
sS'primary tumor site'
p4
I1
sS'laterality'
p5
I1
sS'implant(s)/metastasis beyond pelvis'
p6
I1
sS'total lymph nodes'
p7
I1
sS'tmn staging'
p8
I1
sS'surface involvement'
p9
I1
sS'lymphovascular invasion'
p10
I1
sS'tumor type'
p11
I1
sS'character of parenchyma'
p12
I1
sS'necrosis present'
p13
I1
sS'percent solid'
p14
I1
sS'specimen'
p15
I1
sS'dominant tumor size'
p16
I1
sS'omentum tumor size'
p17
I1
sS'fallopian tube involvement'
p18
I1
sS'status of capsule'
p19
I1
sS'stic (carcinoma in situ)'
p20
I1
sS'extent of tumor spread'
p21
I1
sS'implant(s)/metastasis within pelvis'
p22
I1
sS'tumor size'
p23
I1
sS'percent cystic'
p24
I1
sS'tumor grade'
p25
I1
sS'procedure'
p26
I1
ssS'uterine cancer'
p27
(dp28
S'number positive'
p29
I1
sS'msh6 (present, absent, inconclusive)'
p30
I1
sS'associated endometrial change'
p31
I1
sS'total lymph nodes'
p32
I1
sS'margins'
p33
I1
sS'size'
p34
I1
sS'or adnexa)'
p35
I1
sS'uterine cancer staging summary'
p36
I1
sS'adnexa'
p37
I1
sS'tumor type'
p38
I1
sS'tumor marker studies'
p39
I1
sS'tumor bank'
p40
I1
sS'endocervical involvement'
p41
I1
sS'parametrial'
p42
I1
sS'overall'
p43
I1
sS'lymphatic/vascular invasion'
p44
I1
sS'pms2 (present, absent, inconclusive)'
p45
I1
sS'architectural'
p46
I1
sS'depth of invasion (mm)'
p47
I1
sS'distant metastasis'
p48
I1
sS'(stromal)'
p49
I1
sS'figo grade'
p50
I1
sS'(excluding vagina, pelvic serosa'
p51
I1
sS'serosal involvement'
p52
I1
sS'extrauterine involvement'
p53
I1
sS'uterine wall thickness (mm)'
p54
I1
sS'nuclear'
p55
I1
sS'american joint committee on cancer (2009) tumor-node-metastasis (tmn) staging for endometrial cancer'
p56
I1
ss.